A new wave of US biosimilar patent disputes begins
After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow
After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow
In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change
Despite holding thousands of patents and being active for over 20 years, Docket Navigator data shows that the firm’s entities have filed just 32 litigation actions since 2008
In an exclusive interview, Tim Moss talks through the five years he spent leading the agency and provides an update on its current study of SEP/FRAND policy issues
02 August 2022
Domestic entities lead the charge, with authorities also keen to encourage further international filings
02 August 2022
Filing in Waco now seems a real gamble, as a deep dive on Docket Navigator reveals that most of Alan Albright’s colleagues have handled a relatively low number of cases
01 August 2022
Marianne Frydenlund joins the firm from Nordic Semicondustor with a brief to develop solutions for IoT-related sectors beyond auto
01 August 2022
Legislators put pharma companies under the microscope and blame a law signed by President Trump in 2017 for patent-based payment mitigation
01 August 2022
Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days
31 July 2022
A recent decision handed down by the Boards of Appeal may mean greater patenting opportunities for innovators using AI to help create their inventions
30 July 2022
As the Advancing Diversity Across Patent Teams programme launches, Micheal L Binns expands on the company’s DEI efforts
29 July 2022
The French company is one of several big pharmas to have offloaded deprioritised drugs in recent months
29 July 2022
Michael Pinczuk and his colleague Keira Moore explain that deep thinking about strategy and communication have paid dividends for the leading medtech company
29 July 2022
Get unlimited access to all IAM content